Buffalo, NY – State University of New York at Buffalo (UB) researchers are highlighting a new drug therapy that eliminates tinnitus with a single dose in animal models, as well as other advances, at the Fifth Tinnitus Research Initiative Conference.

Sponsored in part by UB’s Center for Hearing and Deafness, the reportedly sold-out conference is titled “The Neuroscience of Tinnitus,” and is being held August 19-21 in Grand Island, NY.

A UB press release stated that top tinnitus researchers and clinicians from the United States, Europe, Canada, and Asia will attend the conference, which is co-sponsored by the Tinnitus Research Initiative at the University of Regensburg, Germany.

Edward Lobarinas, PhD, assistant research professor of communicative disorders and sciences, will present work showing that two potassium ion channel modulators, called Maxipost and R-Maxipost, completely eliminated behavioral evidence of tinnitus in animals with drug-induced tinnitus. However, further research is needed to determine if these compounds suppress other forms of tinnitus.

Content provided by HearingReview